Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 10, 2024 (Week 32)
Reporting Area Gonorrhea §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 4,527 13,129 287,298 368,813
New England 26 450 5,918 9,852
Connecticut - 114 - 2,559
Maine - 25 369 349
Massachusetts - 244 4,484 5,711
New Hampshire - 26 299 367
Rhode Island 26 212 674 735
Vermont - 8 92 131
Middle Atlantic 735 1,789 41,233 44,597
New Jersey 158 249 5,172 6,054
New York (excluding New York City) - 319 7,096 8,082
New York City 375 836 18,158 19,085
Pennsylvania 202 413 10,807 11,376
East North Central 467 1,681 32,313 47,150
Illinois - 577 5,502 15,085
Indiana 71 232 5,083 6,270
Michigan 62 357 7,488 9,305
Ohio 210 440 10,080 12,275
Wisconsin 124 169 4,160 4,215
West North Central 340 763 17,020 21,151
Iowa 50 87 1,906 2,335
Kansas 36 102 2,017 2,641
Minnesota 50 192 4,277 4,579
Missouri 204 296 6,157 7,968
Nebraska - 72 1,153 1,385
North Dakota - 27 423 765
South Dakota - 59 1,087 1,478
South Atlantic 1,180 4,665 79,390 91,906
Delaware - 54 809 967
District of Columbia 69 140 3,273 3,375
Florida 575 2,716 25,835 28,658
Georgia - 655 16,400 19,042
Maryland - 301 5,484 7,437
North Carolina 1 571 11,771 16,311
South Carolina 233 301 7,079 7,351
Virginia 300 328 8,329 8,187
West Virginia 2 27 410 578
East South Central 299 912 11,140 24,022
Alabama 157 247 5,437 7,431
Kentucky 105 223 2,871 3,404
Mississippi 37 293 2,832 4,689
Tennessee - 393 - 8,498
West South Central 220 1,700 38,928 49,854
Arkansas 54 131 2,871 3,766
Louisiana 108 314 6,384 8,276
Oklahoma 21 165 2,207 4,511
Texas 37 1,167 27,466 33,301
Mountain 229 831 17,189 22,216
Arizona 64 330 7,865 8,635
Colorado 97 227 3,457 4,624
Idaho 8 22 320 547
Montana 11 28 448 495
Nevada 4 166 2,408 3,892
New Mexico 4 95 1,336 2,207
Utah 41 71 1,243 1,648
Wyoming - 9 112 168
Pacific 1,031 2,035 44,167 58,065
Alaska 38 65 1,317 1,407
California 728 1,635 35,440 45,963
Hawaii - 51 - 1,107
Oregon 98 133 2,555 3,162
Washington 167 222 4,855 6,426
U.S. Territories - 34 37 703
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 34 37 703
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 4 10 11
Total 4,527 13,155 287,345 369,527
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, confirmed and probable cases only are being published to align with the approved CSTE position statement 22-ID-03, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.